[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Prestige Brand Holdings (PBH)

Prestige Brand Holdings (PBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,341,124
  • Shares Outstanding, K 47,372
  • Annual Sales, $ 1,089 M
  • Annual Income, $ 190,300 K
  • EBIT $ 330 M
  • EBITDA $ 363 M
  • 60-Month Beta 0.35
  • Price/Sales 2.10
  • Price/Cash Flow 9.49
  • Price/Book 1.24

Options Overview Details

View History
  • Implied Volatility 44.58% (+4.65%)
  • Historical Volatility 33.80%
  • IV Percentile 71%
  • IV Rank 57.73%
  • IV High 71.88% on 12/05/25
  • IV Low 7.31% on 09/05/25
  • Expected Move (DTE 12) 0.00 (0.00%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 96
  • Volume Avg (30-Day) 65
  • Put/Call OI Ratio 1.46
  • Today's Open Interest 1,159
  • Open Int (30-Day) 1,042
  • Expected Range 49.42 to 49.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.89
  • Number of Estimates 3
  • High Estimate $0.92
  • Low Estimate $0.87
  • Prior Year $0.95
  • Growth Rate Est. (year over year) -6.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.81 +10.29%
on 06/03/26
49.81 -0.78%
on 06/09/26
+3.59 (+7.83%)
since 06/02/26
3-Month
42.62 +15.95%
on 05/14/26
60.29 -18.03%
on 04/27/26
-3.06 (-5.83%)
since 04/02/26
52-Week
42.62 +15.95%
on 05/14/26
80.69 -38.75%
on 07/03/25
-30.76 (-38.36%)
since 07/02/25

Most Recent Stories

More News
Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes

TARRYTOWN, N.Y., June 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...

PBH : 49.42 (+2.62%)
Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, HBSS Investigating

SAN FRANCISCO , June 25, 2026 /PRNewswire/ -- Investors in Prestige Consumer Healthcare ( NYSE: PBH ) saw the price of their shares fall over 11% on May 14, 2026 after the company revealed significant...

PBH : 49.42 (+2.62%)
Prestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®

TARRYTOWN, N.Y., June 15, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige”) today announced that it has closed the previously announced acquisition of the Breathe...

PBH : 49.42 (+2.62%)
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES , June 11, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prestige Consumer...

PBH : 49.42 (+2.62%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH

NEW YORK , June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors...

PBH : 49.42 (+2.62%)
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES , June 8, 2026 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prestige...

PBH : 49.42 (+2.62%)
Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference

TARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26 th Annual Consumer Growth...

PBH : 49.42 (+2.62%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH

NEW YORK , May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH).  Such investors...

PBH : 49.42 (+2.62%)
Protect Your Investment: Contact Levi & Korsinsky About the Prestige Consumer Healthcare Inc. (PBH) Investigation

New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Prestige Consumer Healthcare Inc. (NYSE: PBH) ("Prestige Consumer Healthcare...

PBH : 49.42 (+2.62%)
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”)...

PBH : 49.42 (+2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products,...

See More

Key Turning Points

3rd Resistance Point 51.56
2nd Resistance Point 50.56
1st Resistance Point 49.99
Last Price 49.42
1st Support Level 48.42
2nd Support Level 47.42
3rd Support Level 46.85

See More

52-Week High 80.69
Fibonacci 61.8% 66.15
Fibonacci 50% 61.66
Fibonacci 38.2% 57.16
Last Price 49.42
52-Week Low 42.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.